CBS and hyperhomocysteinemia: Moreover, recent evidence by Bjørke-Monsen, et al. 2022 showed that severe hyperhomocysteinemia in a patient with PD associated with reduced availability of CBS cofactor, pyridoxal 5-phosphate (PLP) [20].